Chemotherapy Drugs Market Report Forecast (2013-2023)

Date: 9 April 2019

On the basis of type of chemotherapy drug, plant alkaloids and antitumor antibiotics have been witnessing growth at a noteworthy rate over the past few years backed by effective use of these medications for the treatment of several varieties of cancers such as breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumors, etc. Amongst the regions, North America accounts for the largest regional share in the global chemotherapy drugs market in 2018.

However, in the forecast period, the Asia Pacific region is anticipated to advance at the highest pace. Key factors driving the robust growth rate of Asia Pacific region include boosting production of pharmaceuticals, growing incidence of cancer along with government’s focus on medical infrastructural developments.

What are the major Chemotherapy Drugs segments covered in the Azoth Analytics report?

The major Chemotherapy Drugs segments covered in the report include Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others

What are the regions and countries covered in the study on Global Chemotherapy Drugs Market?

The regional markets covered in the report include North America, Europe, APAC and Rest of the World.        

The countries analyzed in the report include U.S, Canada, United Kingdom, Germany, China and India

Name the companies profiled in the report?

The companies profiled in the report include Pfizer, Eli Lilly & Company, Celgene Corporation, Bristol-Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Novartis, Sanofi, Teva Pharmaceutical Industries Limited.

What are the key factors driving the market of Chemotherapy Drugs?

·         Rising Incidence of Cancer.

·         Growing per capita expenditure on healthcare.

·         Rapid medical infrastructure developments.